Telehealth program for preventing diabetes in Hispanic teens
Official title: Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Run by Baylor College of Medicine · NCT06943001 · Data updated 2026-11-12
This study is testing a new online program to help Hispanic teens who are overweight prevent diabetes by making it easier for them and their families to join in.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 16 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Baylor College of Medicine Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | April 12, 2025 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT06943001 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Hispanic adolescents aged 12-16 years with obesity, defined as a BMI at or above the 95th percentile.
✕Probably not a fit
Patients who are currently taking medications that affect activity or glucose metabolism, or those with conditions that prevent normal physical activity, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to adapt an evidence-based diabetes prevention program specifically for Hispanic adolescents aged 12-16 years who are obese. It utilizes a telehealth approach to address barriers such as transportation and childcare, making it easier for families to participate. The study involves focus groups with adolescents and parents to gather insights on program features and technology use, followed by expert panel reviews and usability testing of the adapted program. The goal is to create a feasible and effective intervention that can be delivered remotely.
Why it matters
Potential benefit: If successful, this program could significantly reduce the risk of type 2 diabetes among Hispanic adolescents by providing accessible health education and support.
How similar studies have gone: While telehealth interventions for diabetes prevention are emerging, this specific adaptation for Hispanic adolescents is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-report as Hispanic * obese, defined as body mass index percentile (BMI%) ≥ 95th percentile * ages of 12-16 years * owns his or her own cellphone Exclusion Criteria: * Taking a medication (i.e. steroids) or diagnosed with a condition (i.e. sleep apnea) that influences activity, sleep, and/or cognition * Recent hospitalization or injury that prevents normal physical activity * Pregnant * Currently enrolled in an exercise program or currently using a personal activity monitoring device like Fitbit * Taking medications or diagnosed with a condition that influences activity, glucose metabolism, and/or cognition.
Where it's running
-
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine
Houston, Texas, United States Recruiting
Study contacts
- Study coordinator: Erica Soltero, PhD
- Email: soltero@bcm.edu
- Phone: 402-910-0832
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults
This project will test whether 4 weeks of high-intensity interval training or time-restricted eating improves heart and metabolic health in adolescents and young adults with overweight or obesity.
-
Telehealth program for weight management and related health issues
This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.
-
Investigating the impact of KATP channel loss on insulin secretion in type 2 diabetes
This study is testing how a medication called glipizide affects insulin release in people with type 2 diabetes to see if losing certain channels in the body makes it harder to manage blood sugar, especially in those who are obese.
-
Effects of enavogliflozin on heart and blood vessel function in obese patients
This study tests if the drug enavogliflozin can improve heart and blood vessel function in obese patients and help them exercise better.
-
Investigating inflammation's role in heart disease and diabetes
This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.